JAK-mediated signaling inhibits Fas ligand-induced apoptosis independent of de novo protein synthesis

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 320-327

  Cousens, Leslie P ^a   Goulette, Frederick A ^a   Darnowski, James W ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CASPASE 8; CELL DNA; CYCLOHEXIMIDE; FAS LIGAND; JANUS KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; STAT1 PROTEIN; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; DNA CONTENT; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 10844248407     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.320     Document Type: Article

References (51)

1. Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58:2489.
2. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69.
3. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630.
4. Zoon, K. C. 1987. Human interferons: structure and function. Interferon 9:1.
5. Pestka, S. 1997. The Interferon receptors. Semin Oncol. 24:S9.
6. Biron, C. A. 2001. Interferons α and β as immune regulators-a new look. Immunity 14:661.
7. Biron, C. A. 1999. Initial and innate responses to viral infections: pattern setting in immunity or disease. Curr. Opin. Microbiol. 2:374.
8. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521.
9. Yang, C. H., A. Mufti, S. R. Pfeffer, L. Basu, J. G. Kim, and L. M. Pfeffer. 2000. IFNα/β promotes cell survival by activating NF-κB. Proc. Natl. Acad. Sci. USA 97:13631.
10. Yang, C. H., A. Murti, S. R. Pfeffer, J. G. Kim, D. B. Donner, and L. M. Pfeffer. 2001. Interferon α/β promotes cell survival by activating nuclear factor κB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 276:13756.
11. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
12. Scaffidi, C., I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274:22532.
13. Algeciras-Schimnich, A., L. Shen, B. C. Barnhart, A. E. Murmann, J. K. Burkhardt, and M. E. Peter. 2002. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22:207.
14. Petak, I., D. M. Tillman, F. G. Harwood, R. Mihalik, and J. A. Houghton. 2000. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells. Cancer Res. 60:2643.
15. Khaled, A. R., and S. K. Surum. 2002. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2:817.
16. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295.
17. Bowman, T., R. Garcia, J. Turkson, and R. Jove. 2000. STATs in oncogenesis. Oncogene 19:2474.
18. Turkson, J., and R. Jove. 2000. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19:6613.
19. Cousens, L. P., F. A. Goulette, and J. W. Darnowski. 2004. IFNα inhibits FasL-induced apoptosis by a novel mechanism that is independent of new protein synthesis but dependent on JAK activity. In Proceedings of the 95th Annual Meeting of the AACR, Vol. 45. Cadmus Professional Communications, Linthicum, MD, p. 659.
20. Epling-Burnette, P. K., J. H. Liu, R. Catlett-Falcone, J. Turkson, M. Oshiro, R. Kothapalli, Y. Li, J.-M. Wang, H.-F. Yang-Yen, J. Karras, et al. 2001. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107:351.
21. Oshiro, M., T. H. Landowski, R. Catlett-Falcone, L. A. Hazlehurst, M. Huang, R. Jove, and W. S. Dalton. 2001. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells. Clin. Cancer Res. 7:4262.
22. Miyamoto, N., K. Sugita, K. Goi, T. Inukai, K. Lijma, T. Tezuka, S. Kojika, M. Nakamura, K. Kagami, and S. Nakazawa. 2001. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome. Leukemia 15:1758.
23. Bright, J. J., C. Du, and S. Sriram. 1999. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis. J. Immunol. 162:6255.
24. Su, L., and M. David. 2000. Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor: selective inhibition of STAT3 and STAT5 by piceatannol. J. Biol. Chem. 275:12661.
25. Scaffidi, C., J. Volkland, I. Blomberg, I. Hoffmann, P. H. Krammer, and M. E. Peter. 2000. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J. Immunol. 164:1236.
26. Matsui, W., C. A. Huff, M. Vala, J. Barber, B. D. Smith, and R. G. Jones. 2003. Anti-tumor activity of interferon-α in multiple myeloma: role of interleukin 6 and tumor cell differentiation. Br. J. Haematol. 121:251.
27. Thyrell, L., S. Erickson, B. Zhivotovsky, K. Pokrovskaja, and O. Sangfelt. 2002. Mechanisms of interferon-α induced apoptosis in malignant cells. Oncogene 21:1251.
28. David, M. 2002. Signal transduction by type I interferons. BioTechniques Suppl: 53.
29. Pien, G. C., K. B. Nguyen, L. Malmgaare, A. R. Satoskar, and C. A. Biron. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169:5827.
30. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227.
31. Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621.
32. L. J. Biol. Chem. 276:26605.
33. Wilson, D. J., A. Aslessandrini, and R. C. Budd. 1999. MEK1 activation rescues Jurkat T Cell from Fas-induced apoptosis. Cell Immunol. 194:67.
34. Holmstrom, T. H., I. Schmitz, T. S. Soderstrom, M. Poukkula, V. L. Johnson, S. C. Chow, P. H. Krammer, and J. E. Eriksson. 2000. MAP/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19:5418.
35. Gomez-Angelats, M., and J. A. Cidlowski. 2001. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis. J. Biol. Chem. 276:44944.
36. Meng, X. W., M. P. Heldebrant, and S. H. Kaufmann. 2002. Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain. J. Biol. Chem. 277:3776.
37. Jones, R. G., A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W.-C. Yeh, R. Hakem, and P. S. Ohashi. 2002. CD28-dependent activation of protein kinase B/AKT blocks Fas-mediated apoptosis by preventing death-inducing signaling complex activity. J. Exp. Med. 196:335.
38. Kennedy, N. J., and R. C. Budd. 1998. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas. J. Immunol. 160:4881.
39. Reinehr, R., F. Schliess, and D. Haussinger. 2003. Hyperosmolarity and CD95L trigger CD95/EGFR association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEB J.
40. Holmstrom, T. H., and J. E. Eriksson. 2000. Phosphorylation-based signaling in Fas receptor-mediated apoptosis. Crit. Rev. Immunol. 20:121.
41. Wang, Y., T. R. Wu, S. Cai, T. Welte, and Y. E. Chin. 2000. Stat1 as a component of tumor necrosis factor α receptor 1-TRADD signaling complex to inhibit NF-κB activation. Mol. Cell Biol. 20:4505.
42. Newton, K., A. W. Harris, M. L. Bath, K. G. Smith, and A. Strasser. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17:706.
43. Walsh, C. M., B. G. Wen, A. M. Chinnaiyan, K. O'Rourke, V. M. Dixit, and S. M. Hedrick. 1998. A role for FADD in T cell activation and development. Immunity 8:439.
44. Yeh, W. C., J. L. Pompa, M. E. McCurrach, H. B. Shu, A. J. Elia, A. Shahinian, M. Ng, A. Wakeham, W. Khoo, K. Mitchell, et al. 1998. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279:1914.
45. Zhang, J., D. Cado, A. Chen, N. H. Kabra, and A. Winoto. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392:296.
46. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
47. Aggarwal, B. B., S. Singh, R. LaPushin, and K. Totpal. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5.
48. Kennedy, N. J., T. Kataoka, J. Tschopp, and R. C. Budd. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891.
49. Bai, J., and J. A. Odin. 2003. Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun. Rev. 2:36.
50. Pignone, A., G. Fiori, A. Del Rosso, S. Generini, and M. Matucci-Cerinic. 2002. The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. Autoimmun. Rev. 1:226.
51. Selliah, N., J. Shackelford, J. F. Wang, F. Traynor, J. Yin, and T. H. Finkel. 2003. T cell signaling and apoptosis in HIV disease. Immunol. Res. 27:247.